AI Insight: Amgen's current price at $344.22 sits significantly below the PERT-weighted fair value of $609.57, indicating notable undervaluation with high confidence. Strong profitability and efficiency contrast with weak leverage and growth scores, reflecting financial stability but growth constraints. Monte Carlo analysis reveals high upside potential and low downside risk, albeit with substantial volatility.